Skip to main content
. 2018 Jul 23;34(12):2118–2126. doi: 10.1093/ndt/gfy204

Table 4.

Antibiotic prescription for prevention and treatment of peritonitis among facilities in PDOPPS (percentage within country)

Facility characteristics ANZ Canada Japan Thailand UK USA
Number of facilities 18 20 28 22 17 65
Antibiotics at home prior to seeking medical attention, %
 Yes, all patients 6 10 0 0 0 40
 Yes, some patients 0 20 15 5 6 11
 No patients 94 70 85 96 94 49
After-hours nurse provides care at PD facility, % 7 25 33 55 12 55
Number of antibiotics against Pseudomonas aeruginosa, %
 1 only 11 5 56 27 29 15
 2 89 95 44 68 65 83
 >2 0 0 0 5 6 2
Initial antibiotic administration for treatment of an exit-site infection, %
 Oral 83 75 68 82 71 73
 Intraperitoneal 17 0 7 0 18 19
 Topical 0 25 25 18 12 8
Initial antibiotic administration for PD catheter tunnel infection, %
 Oral 28 50 86 57 53 43
 Intraperitoneal 61 45 4 10 18 56
 Other 11 5 11 33 29 2
Empiric antibiotic treatment for peritonitisa, %
 First-generation cephalosporin 72 70 63 91 0 40
 Second- or third-generation cephalosporin 33 50 63 91 12 60
 Vancomycin 33 45 15 10 88 83
 Aminoglycoside 72 45 26 10 77 32
 Other 11 35 37 10 41 17
a

Medical directors could choose more than one answer so column percentages may not add up to 100%.